AI assistant
ANGIODYNAMICS INC — Director's Dealing 2016
Jul 29, 2016
32939_dirs_2016-07-29_d3ea94f1-cf84-466c-9182-da3d3aafadb2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2016-07-27
Reporting Person: Clemmer James C (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-07-27 | Common Stock | A | 21191 | — | Acquired | 71191 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-07-27 | Non-Qualified Stock Option (right to buy) | $16.59 | A | 74642 | Acquired | 2023-07-27 | Common Stock (74642) | Direct |
Footnotes
F1: This acquisition of 21,191 shares of common stock ("Common Stock") of AngioDynamics, Inc.(the "Company"), represents 21,191 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal installments beginning on July 27, 2017, such that 25% of the restricted stock units will vest on each of July 27, 2017, 2018, 2019 and 2020.
F2: These stock options vest in four equal annual installments beginning on July 27, 2017, such that 25% of the options will vest on each of July 27, 2017, 2018, 2019 and 2020.